BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8638206)

  • 21. Prolonged paralysis with atracurium infusion.
    Snyder RW
    Crit Care Med; 1995 Jun; 23(6):1157-8. PubMed ID: 7774235
    [No Abstract]   [Full Text] [Related]  

  • 22. [Profile of the effect of succinylcholine after pre-curarization with atracurium, vecuronium or pancuronium].
    Ebeling BJ; Keienburg T; Hausmann D; Apffelstaedt C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Jun; 31(5):304-8. PubMed ID: 8767244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-resistance to both atracurium- and vecuronium-induced neuromuscular blockade in a critically ill patient.
    Fish DN; Singletary TJ
    Pharmacotherapy; 1997; 17(6):1322-7. PubMed ID: 9399619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The shifting sands of mechanical ventilation.
    Hoyt JW
    Crit Care Med; 1998 Jul; 26(7):1162-3. PubMed ID: 9671363
    [No Abstract]   [Full Text] [Related]  

  • 25. [Muscle relaxants in the ICU].
    Schneider G
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 May; 44(5):358-64; quiz 366, 379. PubMed ID: 19440945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolonged paralysis after neuromuscular blockade.
    Gooch JL
    J Toxicol Clin Toxicol; 1995; 33(5):419-26. PubMed ID: 7650766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anaphylaxis by atracurium. One case report].
    Domínguez-Sansores L; González-Díaz S; Arias-Cruz A; Palacios-Rìos D; López-Cabrera NG
    Rev Alerg Mex; 2013; 60(2):78-81. PubMed ID: 24008107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: mechanisms at the cellular and molecular levels.
    Larsson L; Li X; Edström L; Eriksson LI; Zackrisson H; Argentini C; Schiaffino S
    Crit Care Med; 2000 Jan; 28(1):34-45. PubMed ID: 10667496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visual disturbance and residual paralysis.
    Lam AM
    Anesthesiology; 1997 Nov; 87(5):1257-9. PubMed ID: 9366487
    [No Abstract]   [Full Text] [Related]  

  • 30. Further experiences with vercuronium in the horse.
    Martin-Flores M; Campoy L; Gleed RD
    Vet Anaesth Analg; 2012 Mar; 39(2):218-9. PubMed ID: 22356417
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prolonged paralysis after administration of pancuronium bromide].
    Salehi E
    Z Prakt Anasth Wiederbeleb Intensivther; 1972 Aug; 7(4):207-11. PubMed ID: 4269040
    [No Abstract]   [Full Text] [Related]  

  • 32. Incidence of intra-operative bradycardia. Comparison of atracurium and vecuronium in gynaecological surgery.
    Hameedullah H; Khan FA
    Anaesthesia; 1997 Dec; 52(12):1221-4. PubMed ID: 9485981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonged weakness after cisatracurium infusion: a case report.
    Davis NA; Rodgers JE; Gonzalez ER; Fowler AA
    Crit Care Med; 1998 Jul; 26(7):1290-2. PubMed ID: 9671384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A response to 'Masseter muscle spasm following atracurium', Reddy K & Bromley L, Anaesthesia 2004; 59: 513.
    Jenkins G
    Anaesthesia; 2004 Jul; 59(7):733-4. PubMed ID: 15200573
    [No Abstract]   [Full Text] [Related]  

  • 35. [Utility of double burst stimulation in the detection of residual neuromuscular blockade].
    Ortiz JR
    Rev Esp Anestesiol Reanim; 1999 Feb; 46(2):71-4. PubMed ID: 10100441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Skin reactions to intradermal neuromuscular blocking agent injections: a randomized multicenter trial in healthy volunteers.
    Mertes PM; Moneret-Vautrin DA; Leynadier F; Laxenaire MC
    Anesthesiology; 2007 Aug; 107(2):245-52. PubMed ID: 17667568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anaphylaxis to neuromuscular-blocking drugs: all neuromuscular-blocking drugs are not the same.
    Mertes PM; Volcheck GW
    Anesthesiology; 2015 Jan; 122(1):5-7. PubMed ID: 25383569
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of nondepolarizing neuromuscular blocking agents in mechanically ventilated patients.
    May JR; Rutkowski AF
    J Med Assoc Ga; 1994 Aug; 83(8):473-6, 484. PubMed ID: 7822974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early recognition of risk factors for persistent effects of vecuronium.
    Sanders KA; Aucker R
    South Med J; 1996 Apr; 89(4):411-4. PubMed ID: 8614883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neonatal atracurium toxicity may be explained by atracurium moieties.
    Rieder J; Lirk P
    Paediatr Anaesth; 2002 Sep; 12(7):656-7. PubMed ID: 12358671
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.